Recent Work
-
Patients Deserve Immediate Access to FDA-Approved Innovations — Not Bureaucratic Restrictions
Nonresident Senior Fellow Joe Grogan argues that the FDA approval process is slowing down drug innovation.
Categorized in
Nonresident Senior Fellow Joe Grogan argues that the FDA approval process is slowing down drug innovation.